CytoDyn, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Vancouver WA United States (2002)

Organization Overview

First Clinical Trial
2004
NCT00110591
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CytoDyn, Inc.